4//SEC Filing
SLONIN JONATHAN 4
Accession 0001396814-24-000013
CIK 0001396814other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 5:24 PM ET
Size
7.9 KB
Accession
0001396814-24-000013
Insider Transaction Report
Form 4
SLONIN JONATHAN
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-01-03+10,000→ 10,000 totalExercise: $32.07Exp: 2034-01-03→ Common Stock (10,000 underlying) - Award
Common Stock
2024-01-02+5,000→ 51,196.475 total
Footnotes (3)
- [F1]Represents restricted stock units that vest in four equal annual installments beginning on January 2, 2025, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
- [F2]Includes 311.535 shares of common stock acquired under the issuer's employee stock purchase plan in December 2023.
- [F3]The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.
Documents
Issuer
Pacira BioSciences, Inc.
CIK 0001396814
Entity typeother
Related Parties
1- filerCIK 0001875723
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 5:24 PM ET
- Size
- 7.9 KB